Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 August 2021 | Story Ruan Bruwer
Louzanne Coetzee at the Paralympics in Tokyo with her two guides, Claus Kempen (left) and Estean Badenhorst. She is one of 34 members in Team South Africa.

For some athletes, the postponement of the Paralympics was a big frustration, but for Louzanne Coetzee it was a ‘blessing in disguise’.

According to the former University of the Free State (UFS) student and current Residence Head of Akasia on the UFS Bloemfontein Campus, she was more than happy to get another 12 months to prepare herself to the very best of her ability. She will be in action at the Tokyo Paralympics in the 1 500 m on Sunday (29 August 2021) and Monday (30 August). On 5 September, she will tackle the marathon. It is her second Paralympics. 

“This is the most exited I have ever been for an event. It has been so long since I was able to compete on a high level. I think it is a blessing in disguise. It allowed me more time to prepare. I’m in a great state and I cannot wait,” she said.

In the 1 500 m, Coetzee will be guided by Estean Badenhorst. In the marathon she will run next to Claus Kempen, with whom she has completed a couple of marathons before.
“They are both very experienced and I’m fortunate to have such a great team with me. When you are running an event like the 1 500 m, you need to fully trust your guide with his decision making.”

“The main focus is the track item. I won’t put too much pressure on myself in the marathon. The prime goal is to gain experience in the longer distance, because that is where I’ll be shifting in the future,” she explained.

The South African 1 500 m record holder in the T11 classification (totally blind) clocked a personal best time of 4:51.65 in 2019. She is the world record holder in the 5 000 m; however, the item does not feature on the Paralympic programme. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept